Protocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C)
Clinical trial NCT05388500 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05388500
- Sponsor
- Institut de cancérologie Strasbourg Europe
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-15
- Primary completion
- 2030-12-15
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.